Articles tagged "Heart transplant patients"

2019 American Transplant Congress
Mycophenolic Acid Area under the Curve Monitoring via Limited Sampling Strategy in Pediatric Heart Transplant Recipients
S. Crow, S. H. Dahl, J. N. Johnson
Mayo Clinic, Rochester, MN
*Purpose: The study aim was to investigate exposure to mycophenolic acid (MPA), the active metabolite of mycophenolate mofetil (MMF), after pediatric orthotopic heart transplantation (pOHT).…
2019 American Transplant Congress
Infectious Complications in 71 Heart Transplant Recipients at King Chulalongkorn Memorial Hospital, Thailand
N. Sangpornsuk¹, J. Wanichwatphibun², A. Ariyachaipanich³, P. Ongcharit⁴, K. Jutivorakool⁵, J. Vanichanan⁵
¹Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, ²Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, ³Excellent Center for Organ Transplantation, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, ⁴Cardiothoracic Surgery Unit, Department of Surgery, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, ⁵Division of Infectious Diseases, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
*Purpose: Infections have been known as one of the major complication associated with morbidity and mortality especially in the first year following orthotropic heart transplantation…
2019 American Transplant Congress
Exercise after Heart Transplantation: What is the Reality?
A. Velleca, K. Norland, N. Musto, N. Mikhail, H. Barone, G. Jamero, R. J. Levine, S. Dimbil, R. Sharoff, E. Passano, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Heart transplantation (HTx) offers patients a second chance at life and to engage in the daily activities of life. However, the denervated heart does…
2019 American Transplant Congress
CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R+ Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants
M. Jarque¹, A. Cachero², E. Garcia-Romero³, L. Lladó², C. Baliellas², C. Diez³, E. Melilli⁴, J. Fabregat², J. Gonzalez-Costello³, O. Bestard⁴
¹Experimentall Nephrology laboratory, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, ²Liver Transplant Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ³Heart Transplant Unit, Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ⁴Kidney Transplantation Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain
*Purpose: While monitoring CMV-specific cell-mediated immunity(CMI) has shown to be effective in predicting the risk of CMV infection, comparisons across different solid organ transplants(SOT) and…
2019 American Transplant Congress
Room for Improvement: Adherence to Vaccination Recommendations in a Heart Transplant Cohort
D. Jandhyala, J. D. Lewis
Medical University of South Carolina, Charleston, SC
*Purpose: Vaccination of solid organ transplant (SOT) candidates and recipients is vital to decrease infection-related morbidity and mortality. However, published reports have shown that adherence…
2019 American Transplant Congress
High Prevalence of Allergic Disorders but No Specific Immune Phenotype Pattern in Children Awaiting Transplantation
T. B. Kim¹, Y. Avitzur², L. Ionescu¹, U. Allen², S. Mital², B. Foster³, T. Blydt-Hansen⁴, L. Hamiwka⁵, P. Birk⁶, V. Phan⁷, S. Urschel¹
¹University of Alberta, Edmonton, AB, Canada, ²Hospital for Sick Children, Toronto, ON, Canada, ³McGill University, Montreal, QC, Canada, ⁴University of British Columbia, Vancouver, BC, Canada, ⁵University of Calgary, Calgary, AB, Canada, ⁶University of Manitoba, Winnipeg, MB, Canada, ⁷Université de Montréal, Montreal, QC, Canada
*Purpose: Allergic disorders (AD) occur more frequently in children after transplantation (Tx) compared to healthy children, reflecting an imbalance of the immune system in the…
2019 American Transplant Congress
Cardioprotective Effects of Pre-Operative Cyclosporine in Patients Undergoing Heart Transplantation
Y. Hirase, M. Harris, M. Watson, H. Lee, C. Patel
Duke University Hospital, Durham, NC
*Purpose: The purpose of this study is to determine if pre-operative cyclosporine (Cya) decreases the rate of primary graft dysfunction (PGD) in patients undergoing orthotopic…
2019 American Transplant Congress
Association between Recipient Sex and Risk of Heart Graft Failure
A. Chackowicz¹, X. Zhang², M. Dahhou², R. Sapir-Pichhadze³, H. Cardinal⁴, B. Foster⁵
¹Faculty of Medicine, McGill University, Montreal, QC, Canada, ²Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ³Dept. of Medicine, McGill University, Montreal, QC, Canada, ⁴Dept. of Medicine, Université de Montréal, Montreal, QC, Canada, ⁵Dept. of Pediatrics, McGill University, Montreal, QC, Canada
*Purpose: Previous studies of sex differences in heart transplant outcomes focused on interactions between donor and recipient sex, but did not consider the potentially modifying…
2019 American Transplant Congress
Rabbit Anti-Thymocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection
B. Kitto¹, B. Baetz¹, S. Krim², H. Patel², S. Mandras², S. Desai², C. Eiswirth², H. Ventura², S. Thai¹
¹Pharmacy, Ochsner Medical Center, New Orleans, LA, ²Heart Transplant, Ochsner Medical Center, New Orleans, LA
*Purpose: To assess the safety and efficacy of rATG induction in heart transplant recipients at high risk for rejection.*Methods: This was a single-center, retrospective study…
2018 American Transplant Congress
Early Results from USHER: A Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Therapy
R. McLean, P. P. Reese, M. Acker, P. Abt, A. Sicilia, N. Hornsby, P. Atluri, K. R. Reddy, E. Blumberg, V. Van Deerlin, D. S. Goldberg.
UPENN, Philadelphia.
Background: In 2016, over 600 hearts from deceased donors with active or prior hepatitis C virus (HCV) infection were discarded; most were otherwise good quality,…